These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 22299825)

  • 21. Predicting Exposure After Oral Inhalation of the Selective Glucocorticoid Receptor Modulator, AZD5423, Based on Dose, Deposition Pattern, and Mechanistic Modeling of Pulmonary Disposition.
    Bäckman P; Tehler U; Olsson B
    J Aerosol Med Pulm Drug Deliv; 2017 Apr; 30(2):108-117. PubMed ID: 27740878
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The impact of pulmonary diseases on the fate of inhaled medicines--a review.
    Wang YB; Watts AB; Peters JI; Williams RO
    Int J Pharm; 2014 Jan; 461(1-2):112-28. PubMed ID: 24291124
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pulmonary absorption rate and bioavailability of drugs in vivo in rats: structure-absorption relationships and physicochemical profiling of inhaled drugs.
    Tronde A; Nordén B; Marchner H; Wendel AK; Lennernäs H; Bengtsson UH
    J Pharm Sci; 2003 Jun; 92(6):1216-33. PubMed ID: 12761811
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Interpretation and prediction of inhaled drug particle accumulation in the lung and its associated toxicity.
    Jones RM; Neef N
    Xenobiotica; 2012 Jan; 42(1):86-93. PubMed ID: 22106935
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Preclinical Experimental and Mathematical Approaches for Assessing Effective Doses of Inhaled Drugs, Using Mometasone to Support Human Dose Predictions.
    Caniga M; Cabal A; Mehta K; Ross DS; Gil MA; Woodhouse JD; Eckman J; Naber JR; Callahan MK; Goncalves L; Hill SE; Mcleod RL; McIntosh F; Freke MC; Visser SA; Johnson N; Salmon M; Cicmil M
    J Aerosol Med Pulm Drug Deliv; 2016 Aug; 29(4):362-77. PubMed ID: 26859446
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Symposium Summary: "Breathe In, Breathe Out, Its Easy: What You Need to Know About Developing Inhaled Drugs".
    Tepper JS; Kuehl PJ; Cracknell S; Nikula KJ; Pei L; Blanchard JD
    Int J Toxicol; 2016 Jul; 35(4):376-92. PubMed ID: 26857693
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Fundamentals and Applications of Isolated Perfused Lung (IPL) Model in the Development of Pulmonary Drug Delivery.
    Mireskandari K; Ardakani YH; Moghadam ES; Ketabchi F; Rouini M
    Curr Drug Deliv; 2023; 20(10):1425-1440. PubMed ID: 36017864
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Optimizing DMPK Properties: Experiences from a Big Pharma DMPK Department.
    Sohlenius-Sternbeck AK; Janson J; Bylund J; Baranczewski P; Breitholtz-Emanuelsson A; Hu Y; Tsoi C; Lindgren A; Gissberg O; Bueters T; Briem S; Juric S; Johansson J; Bergh M; Hoogstraate J
    Curr Drug Metab; 2016; 17(3):253-70. PubMed ID: 26651977
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Advances in experimental and mechanistic computational models to understand pulmonary exposure to inhaled drugs.
    Bäckman P; Arora S; Couet W; Forbes B; de Kruijf W; Paudel A
    Eur J Pharm Sci; 2018 Feb; 113():41-52. PubMed ID: 29079338
    [TBL] [Abstract][Full Text] [Related]  

  • 30. AZD7624, an Inhaled p38 Inhibitor, Demonstrates Local Lung Inhibition of LPS-Induced TNF
    Pehrson R; Hegelund-Myrbäck T; Cunoosamy D; Asimus S; Jansson P; Patel N; Borde A; Lundin S
    J Pharmacol Exp Ther; 2018 Jun; 365(3):567-572. PubMed ID: 29549158
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Insights on animal models to investigate inhalation therapy: Relevance for biotherapeutics.
    Guillon A; Sécher T; Dailey LA; Vecellio L; de Monte M; Si-Tahar M; Diot P; Page CP; Heuzé-Vourc'h N
    Int J Pharm; 2018 Jan; 536(1):116-126. PubMed ID: 29180257
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A European perspective on orally inhaled products: in vitro requirements for a biowaiver.
    García-Arieta A
    J Aerosol Med Pulm Drug Deliv; 2014 Dec; 27(6):419-29. PubMed ID: 25238116
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Conference report: 1st Medicon Valley Inhalation Symposium.
    Lastow O
    Ther Deliv; 2013 Feb; 4(2):149-51. PubMed ID: 23343154
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Translation of Inhaled Drug Optimization Strategies into Clinical Pharmacokinetics and Pharmacodynamics Using GSK2292767A, a Novel Inhaled Phosphoinositide 3-Kinase
    Begg M; Edwards CD; Hamblin JN; Pefani E; Wilson R; Gilbert J; Vitulli G; Mallett D; Morrell J; Hingle MI; Uddin S; Ehtesham F; Marotti M; Harrell A; Newman CF; Fernando D; Clark J; Cahn A; Hessel EM
    J Pharmacol Exp Ther; 2019 Jun; 369(3):443-453. PubMed ID: 30940692
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pharmacokinetics of epimeric budesonide and fluticasone propionate after repeat dose inhalation--intersubject variability in systemic absorption from the lung.
    Minto C; Li B; Tattam B; Brown K; Seale JP; Donnelly R
    Br J Clin Pharmacol; 2000 Aug; 50(2):116-24. PubMed ID: 10930963
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clinical perspectives on pulmonary systemic and macromolecular delivery.
    Scheuch G; Kohlhaeufl MJ; Brand P; Siekmeier R
    Adv Drug Deliv Rev; 2006 Oct; 58(9-10):996-1008. PubMed ID: 16996638
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparison of inhaled corticosteroids: an update.
    Kelly HW
    Ann Pharmacother; 2009 Mar; 43(3):519-27. PubMed ID: 19261959
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Challenges for pulmonary delivery of high powder doses.
    Sibum I; Hagedoorn P; de Boer AH; Frijlink HW; Grasmeijer F
    Int J Pharm; 2018 Sep; 548(1):325-336. PubMed ID: 29991452
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The nanoscale in pulmonary delivery. Part 1: deposition, fate, toxicology and effects.
    Rogueda PG; Traini D
    Expert Opin Drug Deliv; 2007 Nov; 4(6):595-606. PubMed ID: 17970663
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Feasibility and safety of targeted cisplatin delivery to a select lung lobe in dogs via the AeroProbe intracorporeal nebulization catheter.
    Selting K; Waldrep JC; Reinero C; Branson K; Gustafson D; Kim DY; Henry C; Owen N; Madsen R; Dhand R
    J Aerosol Med Pulm Drug Deliv; 2008 Sep; 21(3):255-68. PubMed ID: 18759657
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.